ArticleOncotarget2019

Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells.

Audrey Turchick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.